170 related articles for article (PubMed ID: 1316970)
1. Antibacterial activity of a 1,8-naphthyridine quinolone, PD 131628.
Lewin CS
J Med Microbiol; 1992 May; 36(5):353-7. PubMed ID: 1316970
[TBL] [Abstract][Full Text] [Related]
2. Bactericidal activity of the new 4-quinolones DU-6859a and DV-7751a.
Morrissey I; Smith JT
J Med Microbiol; 1995 Jul; 43(1):4-8. PubMed ID: 7608954
[TBL] [Abstract][Full Text] [Related]
3. Bactericidal action of PD127,391, an enhanced spectrum quinolone.
Lewin CS; Amyes SG
J Med Microbiol; 1990 Sep; 33(1):67-70. PubMed ID: 2231674
[TBL] [Abstract][Full Text] [Related]
4. Bactericidal activity of trovafloxacin (CP-99,219).
Morrissey I
J Antimicrob Chemother; 1996 Dec; 38(6):1061-6. PubMed ID: 9023654
[TBL] [Abstract][Full Text] [Related]
5. The bactericidal activity of sparfloxacin.
Lewin CS; Morrissey I; Smith JT
J Antimicrob Chemother; 1992 Nov; 30(5):625-32. PubMed ID: 1337350
[TBL] [Abstract][Full Text] [Related]
6. The fluoroquinolones exert a reduced rate of kill against Enterococcus faecalis.
Lewin CS; Morrissey I; Smith JT
J Pharm Pharmacol; 1991 Jul; 43(7):492-4. PubMed ID: 1682462
[TBL] [Abstract][Full Text] [Related]
7. Bactericidal index: a new way to assess quinolone bactericidal activity in vitro.
Morrissey I
J Antimicrob Chemother; 1997 Jun; 39(6):713-7. PubMed ID: 9222039
[TBL] [Abstract][Full Text] [Related]
8. Comparative killing kinetics of the novel des-fluoro(6) quinolone BMS-284756, fluoroquinolones, vancomycin and beta-lactams.
Gradelski E; Valera L; Kolek B; Bonner D; Fung-Tomc J
Int J Antimicrob Agents; 2001 Jul; 18(1):43-8. PubMed ID: 11463525
[TBL] [Abstract][Full Text] [Related]
9. Antibacterial activity of quinolones against coagulase-negative staphylococci and the quinolone resistance-determining region of the gyrA genes from six species.
Takahata M; Yonezawa M; Matsubara N; Watanabe Y; Narita H; Matsunaga T; Igarashi H; Kawahara M; Onodera S; Oishi Y
J Antimicrob Chemother; 1997 Sep; 40(3):383-6. PubMed ID: 9338491
[TBL] [Abstract][Full Text] [Related]
10. Antistaphylococcal activity of DX-619, a new des-F(6)-quinolone, compared to those of other agents.
Bogdanovich T; Esel D; Kelly LM; Bozdogan B; Credito K; Lin G; Smith K; Ednie LM; Hoellman DB; Appelbaum PC
Antimicrob Agents Chemother; 2005 Aug; 49(8):3325-33. PubMed ID: 16048943
[TBL] [Abstract][Full Text] [Related]
11. Postantibiotic effects of E-4868 and OPC-17116.
Sanford MD; Jones RN
J Antimicrob Chemother; 1993 Dec; 32(6):916-7. PubMed ID: 8144440
[No Abstract] [Full Text] [Related]
12. Improved bactericidal activity of Q-35 against quinolone-resistant staphylococci.
Ito T; Matsumoto M; Nishino T
Antimicrob Agents Chemother; 1995 Jul; 39(7):1522-5. PubMed ID: 7492097
[TBL] [Abstract][Full Text] [Related]
13. In vitro activities of DX-619 and comparison quinolones against gram-positive cocci.
Wickman PA; Black JA; Moland ES; Thomson KS
Antimicrob Agents Chemother; 2006 Jun; 50(6):2255-7. PubMed ID: 16723599
[TBL] [Abstract][Full Text] [Related]
14. Postantibiotic effect of DU-6859a and levofloxacin as compared with ofloxacin.
Houston AK; Jones RN
Diagn Microbiol Infect Dis; 1994 Jan; 18(1):57-9. PubMed ID: 8026158
[TBL] [Abstract][Full Text] [Related]
15. Activity of gatifloxacin and ciprofloxacin in combination with other antimicrobial agents.
Gradelski E; Kolek B; Bonner DP; Valera L; Minassian B; Fung-Tomc J
Int J Antimicrob Agents; 2001 Feb; 17(2):103-7. PubMed ID: 11165113
[TBL] [Abstract][Full Text] [Related]
16. The bactericidal activity of DR-3355, an optically active isomer of ofloxacin.
Lewin CS; Amyes SG
J Med Microbiol; 1989 Nov; 30(3):227-31. PubMed ID: 2479750
[TBL] [Abstract][Full Text] [Related]
17. In vitro investigation of the intraphagocytic bioactivities of ciprofloxacin and the new fluoroquinolone agents, clinafloxacin (CI-960) and PD 131628.
Anderson R; Jooné GK
Chemotherapy; 1993; 39(6):424-31. PubMed ID: 8222871
[TBL] [Abstract][Full Text] [Related]
18. In vitro antibacterial activity of enrofloxacin and ciprofloxacin in combination against Escherichia coli and staphylococcal clinical isolates from dogs.
Lautzenhiser SJ; Fialkowski JP; Bjorling D; Rosin E
Res Vet Sci; 2001 Jun; 70(3):239-41. PubMed ID: 11676620
[TBL] [Abstract][Full Text] [Related]
19. Comparative antimicrobial activity of lomefloxacin, norfloxacin, ofloxacin, ciprofloxacin and enoxacin against > 500 bacterial isolates.
Ismaeel NA; Tayeb OS
Microbios; 1993; 74(300):147-54. PubMed ID: 8396196
[TBL] [Abstract][Full Text] [Related]
20. Postantibiotic effect of ciprofloxacin compared with that of five other quinolones.
Minguez F; Ramos C; Barrientos S; Loscos A; Prieto J
Chemotherapy; 1991; 37(6):420-5. PubMed ID: 1760941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
